780 related articles for article (PubMed ID: 17627899)
1. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
3. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
Madden BP; Allenby M; Loke TK; Sheth A
Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
[TBL] [Abstract][Full Text] [Related]
4. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
[TBL] [Abstract][Full Text] [Related]
7. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
Kothari SS; Duggal B
Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
[TBL] [Abstract][Full Text] [Related]
12. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction.
Sheth A; Park JE; Ong YE; Ho TB; Madden BP
Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248
[TBL] [Abstract][Full Text] [Related]
13. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.
Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; Gibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA
Eur Heart J; 2004 Mar; 25(5):431-6. PubMed ID: 15033256
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension.
Gough MS; White RJ
Liver Transpl; 2009 Jan; 15(1):30-6. PubMed ID: 19109844
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?
Milman N; Burton CM; Iversen M; Videbaek R; Jensen CV; Carlsen J
J Heart Lung Transplant; 2008 Mar; 27(3):329-34. PubMed ID: 18342757
[TBL] [Abstract][Full Text] [Related]
18. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension.
Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M
Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil for pulmonary hypertension secondary to congenital heart diseases.
Gupta A; Kerkar P
Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]